GreenLight Biosciences grabs $50 mln

Boston-based GreenLight Biosciences Inc, a developer of RNA-based solutions for agriculture and pharmaceutical applications, has secured $50 million in funding. S2G Ventures, Baird Capital and Blue I/O led the round.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!